Philadelphia, Pa. – VirMedica, the leader in providing eACCESS technology solutions designed to expedite patient access to biopharmaceutical products, today announced that its Board of Directors has appointed Philip Lee as president, chief executive officer (CEO) and a member of the Board of Directors, effective immediately.
“As we enter an important growth stage for VirMedica, the Board of Directors welcomes Phil’s impressive leadership and industry experience along with his passion and proven success driving corporate performance in the healthcare arena,” said John H. Johnson, chairman of VirMedica. “In his role as president and CEO, Phil will be responsible for advancing VirMedica’s proprietary eACCESS technology, extending our track record of innovation and delivering upon our core mission to expedite the patient journey to potentially life-enhancing biopharmaceutical products,” Johnson added.
Mr. Lee is a seasoned industry leader with more than 35 years of executive management and leadership experience across a wide range of enterprise solutions for Fortune 1000 clients. He has spent the past two decades driving innovation and accelerating drug development for the life sciences industry. Mr. Lee most recently served as president and chief executive officer of PHT Corporation, a leading provider of electronic clinical outcome assessments solutions for the biopharmaceutical industry, which was acquired in 2015 by ERT, a leading provider of patient data collection services. Mr. Lee’s prior executive management positions included serving as president of eXcelon Corporation and as president and CEO of Clinsoft. Earlier in his career, Mr. Lee held roles of increasing responsibility at Bolt, Beranek & Neumann, Interleaf, Inc., Oracle Corporation and Digital Equipment Corporation. Mr. Lee was named Ernst & Young ‘Entrepreneur of the Year’ finalist in 2012 and 2013, one of PharmaVoice’s ‘100 Most Inspirational People in Life Sciences’ and as a ‘Tech Luminary of the Year’ by Mass High Tech and The Boston Business Journal in 2012. Mr. Lee earned a B.S. in Operations Research and Industrial Engineering and a Master of Engineering degree from Cornell University.
“The industry faces unprecedented opportunities and challenges posed by the increasingly complex patient access landscape. There is tremendous demand for technology solutions that can simplify the often-complicated path that providers and their patients must navigate prior to accessing treatment. I look forward to working closely with John, the Board of Directors and management team to further transform the patient access ecosystem, grow VirMedica’s business across all segments of the Company’s enterprise and to better serve our customers and ultimately patients,” said Philip Lee, president and chief executive officer of VirMedica.
VirMedica is the industry leader in providing eACCESS technology solutions designed to expedite patient access to potentially life-enhancing biopharmaceutical products. VirMedica’s proprietary eACCESS platforms are transforming the market access landscape for biopharmaceutical products through simplifying, automating and ultimately accelerating many processes for patients and providers within the market access ecosystem.
For more information, visit www.virmedica.com